AgeX Therapeutics

AgeX Therapeutics, Inc. is a biotechnology company founded in 2017 by world-leading gerontologist and bioentrepreneur Dr. Michael D. West, Ph.D., who has dedicated his life to the pursuit of understanding nature’s secrets of human aging. He is a highly-regarded pioneer in cellular aging, stem cell research, telomerase and cloning. He previously founded Geron Corporation where under his leadership the cell immortalizing gene known as telomerase was first isolated, he led the collaborative effort that resulted in the first isolation of pluripotent stem cells, and he spearheaded pioneering research to reverse the aging of human cells by nuclear transfer and related reprogramming technologies.

The mission of AgeX is to develop and commercialize novel therapeutics targeting biological aging based on an emerging understanding of the ‘clockwork mechanisms’ of human aging. We plan to apply these technologies in the practice of human medicine to extend human health and life spans.